ClinicalTrials.gg

Program

moxidectin

Also written as “Moxidectin” and “Moxidectin 2 MG Oral Tablet”.

Its studies are mostly in Infections · Blepharitis · Onchocerciasis, led by 2 companies.

Furthest: phase 4, since Dec 17, 20095 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Pfizer40 open or runningphase 2since Dec 17, 2009Aug 15, 2008none ahead
Eye Research Foundation10 open or runningphase 4since Jan 22, 2025Jan 22, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 15, 2008First study: phase 1 study in InfectionsNew to PfizerPfizer · NCT00736697 · 54 enrolled · France
  2. Sep 11, 2008Phase 1 study in InfectionsPfizer · NCT00751764 · 12 enrolled · United Kingdom
  3. Mar 4, 2009Phase 1 study in HealthyPfizer · NCT00856362 · 38 enrolled · Germany
  4. Dec 17, 2009Phase 2 study in OnchocerciasisPfizer · NCT01035619
  5. Jan 22, 2025Eye Research Foundation's first study: phase 4 study in BlepharitisNew to Eye Research FoundationEye Research Foundation · NCT06795165 · 24 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT06795165Blepharitis · United States4CompletedEye Research FoundationApr 28, 202524
NCT01035619Onchocerciasis2WithdrawnPfizerApr 20110
NCT00856362Healthy · Germany1CompletedPfizerSep 200938
NCT00751764Infections · United Kingdom1CompletedPfizerSep 200912
NCT00736697Infections · France1CompletedPfizerMay 200954

How it is read

Names in the registry

  • “moxidectin”, 2 entries
  • “Moxidectin”, 2 entries
  • “Moxidectin 2 MG Oral Tablet”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.